Skip to main content

Geert Walther Nygaard, Pamela Harris

Premium
Epigenomics has announced that its supervisory board has unanimously chosen Geert Walther Nygaard as its new CEO. Nygaard will begin his new post Feb. 1.
 
Nygaard joins Epigenomics from Wiesbaden, Germany-based Abbott GmbH & Co. KG where he was managing director. He also held various positions with several diagnostics firms, including Beckman Instruments and Dako.
 

 
Panacea Pharmaceuticals announced that Pamela Harris will be its new VP of medical and clinical affairs. In this position, Harris will lead the design and conduct of clinical trials for Panacea’s therapeutic and diagnostic products for cancer and central nervous system diseases.
 
Previously, Harris was the chief medical officer at Callisto Pharmaceuticals. She also served as a team leader and senior medical director at Pfizer, as well as the director of clinical research at Wyeth Pharmaceuticals and US Bioscience.

Filed under

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.